Literature DB >> 17169955

Patient demographics and centre description in European palliative care units.

Stein Kaasa1, Karin Torvik, Nathan Cherny, Geoffrey Hanks, Franco de Conno.   

Abstract

Patients in palliative care are elderly, frail and in decline with multisystem disease. These and other factors make palliative care research particularly challenging, and has been one of several reasons why relatively little systematic research has been performed. The European Association for Palliative Care (EAPC) is seeking to emphasise the importance of research. The present project is the first empirical multicentre study organised by the EAPC Research Network, with the aim of identifying the patient population using specialised palliative care, and identifying a network of palliative care services across Europe, able to participate in a multicentre collaboration for research. During a designated week in the autumn of 2000, data on patients were recorded from 143 centres. The survey was carried out by means of two questionnaires, one centre questionnaire and one patient questionnaire. Data were submitted on 3013 patients from 22 different European countries. Almost all patients had cancer (94%), while some had neurological disease (3%). The majority (75%) had been referred to a palliative care service during the six to seven months before the survey was performed. Very few patients had less than one week of expected survival (6%), the majority were expected to live one to six months, while as many as 16% were expected to live more than one year. The majority of the patients (27%) were fully ambulatory--the ability to walk independently without any assistance. The majority of the patients (60%) received care as an outpatient, either at a traditional clinic in an outpatient cancer hospital (12%), in home-care programs from a specialised advisory service (24%), or external nursing care (24%). The population of patients included in this survey was not a sample of dying patients. There were a substantial number of patients with an anticipated life expectancy of more than six months. The study demonstrated a considerable enthusiasm for research in the palliative care community across Europe. The heterogeneity of the sample is evident, and this will need careful consideration for future clinical trials. This calls for an international consensus on how to report on patient characteristics within palliative care research. This is necessary in order to be able to evaluate the representativity of the study population, as well as to compare data between studies. The range of services encountered in the survey highlights the need for the organisational and clinical standards for palliative care, which can be audited.

Entities:  

Mesh:

Year:  2007        PMID: 17169955     DOI: 10.1177/0269216306072086

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  11 in total

1.  Cancer pain--progress and ongoing issues in Europe.

Authors:  Stein Kaasa; Sebastiano Mercadante; Augusto Caraceni
Journal:  Pain Res Manag       Date:  2009 Sep-Oct       Impact factor: 3.037

2.  A cross-sectional survey of pain in palliative care in Portugal.

Authors:  Ferraz Gonçalves; Ana Almeida; Catarina Antunes; Maria Cardoso; Margarida Carvalho; Maria Claro; Francisca Coimbra; Inês Diniz; Bruno Fonseca; Emília Fradique; Edna Gonçalves; Florbela Gonçalves; Maria Gonçalves; Américo Magalhães; Paulo Pina; Conceição Pires; Paula Silva; Ricardo Silva; Rui Silva; Filipa Tavares; Laura Teixeira
Journal:  Support Care Cancer       Date:  2013-02-26       Impact factor: 3.603

3.  Interdisciplinary collaboration in hospice team meetings.

Authors:  Elaine Wittenberg-Lyles; Debra Parker Oliver; George Demiris; Kelly Regehr
Journal:  J Interprof Care       Date:  2010-05       Impact factor: 2.338

Review 4.  [Generalist palliative care for non-cancer patients: A review article].

Authors:  K Afshar; K Geiger; G Müller-Mundt; J Bleidorn; N Schneider
Journal:  Schmerz       Date:  2015-12       Impact factor: 1.107

Review 5.  Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.

Authors:  Shirley H Bush; Salmaan Kanji; José L Pereira; Daniel H J Davis; David C Currow; David Meagher; Kiran Rabheru; David Wright; Eduardo Bruera; Michael Hartwick; Pierre R Gagnon; Bruno Gagnon; William Breitbart; Laura Regnier; Peter G Lawlor
Journal:  J Pain Symptom Manage       Date:  2014-01-28       Impact factor: 3.612

6.  An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives.

Authors:  Peter G Lawlor; Daniel H J Davis; Mohammed Ansari; Annmarie Hosie; Salmaan Kanji; Franco Momoli; Shirley H Bush; Sharon Watanabe; David C Currow; Bruno Gagnon; Meera Agar; Eduardo Bruera; David J Meagher; Sophia E J A de Rooij; Dimitrios Adamis; Augusto Caraceni; Katie Marchington; David J Stewart
Journal:  J Pain Symptom Manage       Date:  2014-04-12       Impact factor: 3.612

7.  Inadequate symptom control in advanced cancer patients across Europe.

Authors:  Eivor A Laugsand; Gunnhild Jakobsen; Stein Kaasa; Pål Klepstad
Journal:  Support Care Cancer       Date:  2010-11-30       Impact factor: 3.603

8.  Prevalence of distressing symptoms in hospitalised patients on medical wards: A cross-sectional study.

Authors:  Katrin Ruth Sigurdardottir; Dagny Faksvåg Haugen
Journal:  BMC Palliat Care       Date:  2008-09-23       Impact factor: 3.234

9.  Comparison of terminally ill cancer- vs. non-cancer patients in specialized palliative home care in Germany - a single service analysis.

Authors:  Stephanie Stiel; Maria Heckel; Andreas Seifert; Tobias Frauendorf; Roland Martin Hanke; Christoph Ostgathe
Journal:  BMC Palliat Care       Date:  2015-07-25       Impact factor: 3.234

10.  The support needs of terminally ill people living alone at home: a narrative review.

Authors:  Samar M Aoun; Lauren J Breen; Denise Howting
Journal:  Health Psychol Behav Med       Date:  2014-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.